Comparing hepatic resection and transarterial chemoembolization for barcelona clinic liver cancer (BCLC) stage B hepatocellular carcinoma: Change for treatment of choice?

World Journal of Surgery

Volumn 34, Issue 9, 2010, Pages 2155-2161

  Lin, Chin Ta ^a   Hsu, Kuo Feng ^a   Chen, Teng Wei ^a   Yu, Jyh Cherng ^a   Chan, De Chuan ^a   Yu, Chih Yung ^a   Hsieh, Tsai Yuan ^a   Fan, Hsiu Lung ^a   Kuo, Shih Ming ^a   Chung, Kuo Piao ^b   Hsieh, Chung Bao ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ALGORITHM; ARTICLE; BLOOD; CANCER STAGING; CHEMOEMBOLIZATION; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TAIWAN; TREATMENT OUTCOME;

ADULT; ALGORITHMS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME;

EID: 79952114708     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0598-x     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J et al (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156
2. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750
3. Wakabayashi H, Ushiyama T, Ishimura K et al (2003) Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. J Surg Oncol 82:98-103
4. Lai EC, Fan ST, Lo CM et al (1995) Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg 221:291-298
5. Mor E, Kaspa RT, Sheiner P et al (1998) Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 129:643-653
6. Ota K, Teraoka S, Kawai T (1995) Donor difficulties in Japan and Asian countries. Transplant Proc 27:83-86
7. Mazziotti A, Grazi GL, Cavallari A (1998) Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterology 45 (Suppl 3):1281-1287
8. Fan ST, Lo CM, Liu CL et al (1999) Hepatic resection for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322-330
9. Okuda K, Ohtsuki T, Obata H et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918-928
10. Greene FL, Page DL, Fleming ID (2002) Liver including intrahepatic bile ducts. In: American Joint Committee on Cancer Staging Manual. Springer, New York
11. Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35:519-524
12. Marrero JA, Fontana RJ, Barrat A et al (2005) Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41:707-716
13. Levy I, Sherman M (2002) Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 50:881-885
14. El-Serag HB, Marrero JA, Rudolph L et al (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134:1752-1763
15. Shiina S, Teratani T, Obi S et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122-130
16. Ringe B, Pichlmayr R, Wittekind C et al (1991) Surgical treatment of hepatocellular carcinoma: experience with hepatic resection and transplantation in 198 patients. World J Surg 15:270-285
17. Bruix J, Sala M, Llovet JM (2004) Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 (Suppl 1):S179- S188
18. Capussotti L, Borgonovo G, Bouzari H et al (1994) Results of major hepatic resection for large primary liver cancer in patients with cirrhosis. Br J Surg 81:427-431
19. Shuto T, Hirohashi K, Kubo S et al (1999) Efficacy of major hepatic resection for large hepatocellular carcinoma. Hepatogastroenterology 46:413-416
20. Hanazaki K, Kajikawa S, Shimozawa N et al (2001) Hepatic resection for large hepatocellular carcinoma. Am J Surg 181:347- 353
21. Lee NH, Chau GY, Lui WY et al (1998) Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter. Br J Surg 85:1654-1657
22. Hanazaki K, Kajikawa S, Shimozawa N et al (2002) Hepatic resection for hepatocellular carcinoma in diameter of - or =10 cm. Hepatogastroenterology 49:518-523
23. Poon RT, Fan ST, Wong J (2002) Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 194:592-602
24. Ng KK, Vauthey JN, Pawlik TM et al (2005) Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 12:364-373
25. Hsieh CB, Yu CY, Tzao C et al (2006) Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection. Eur J Surg Oncol 32:72-76
26. European Association for the Study of the Liver (2009) EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 50:227-242
27. Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346-350
28. Pringle JH (1908) Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48:541-549
29. Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734-1739
30. O Suilleabhain CB, Poon RT, Yong JL et al (2003) Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg 90:325-331
31. Yoshioka H, Sato M, Sonomura T et al (1997) Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma. Semin Oncol 24:S6
32. Ono Y, Yoshimasu T, Ashikaga R et al (2000) Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol 23:564-568
33. Bruix J, Llovet JM, Castells A et al (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578-1583
34. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-442
35. Ishizawa T, Hasegawa K, Aoki T et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134:1908-1916